Nexalin Technology (NXL) Cost of Revenue (2021 - 2026)
Nexalin Technology (NXL) posted Cost of Revenue of $3264.0 for Q2 2026, up 79.64% on a QoQ basis from $1817.0 in Q1 2026, and down 85.71% year-over-year from $22838.0 in Q2 2025.
Powered by 
Analysis
Nexalin Technology (NXL) Cost of Revenue (2021 - 2026) Analysis & Trends
Nexalin Technology has reported Cost of Revenue for 6 years, with the latest figure at $3264.0 in Q2 2026.
- On a quarterly basis, Cost of Revenue fell 85.71% year-over-year to $3264.0 in Q2 2026; TTM through Jun 2026 was $30058.0, a 46.88% decrease from a year earlier, with the FY2025 full-year figure at $61373.0, up 67.72% from the prior year.
- Cost of Revenue was $3264.0 for Q2 2026 at Nexalin Technology, up from $1817.0 in the prior quarter.
- The five-year high for Cost of Revenue was $187298.0 in Q3 2022, with the low at $1817.0 in Q1 2026.
- Average Cost of Revenue over 5 years is $27330.4, with a median of $8326.0 recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Cost of Revenue surged 1912.66% in 2022, then sank 97.88% in 2023.
- Over 5 years, Cost of Revenue stood at $6867.0 in 2022, then decreased by 23.82% to $5231.0 in 2023, then jumped by 43.3% to $7496.0 in 2024, then jumped by 180.54% to $21029.0 in 2025, then slumped by 84.48% to $3264.0 in 2026.
- The last three Cost of Revenue figures came in at $3264.0 (Q2 2026), $1817.0 (Q1 2026), and $21029.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn | 931.90 Mn |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn | 3.42 Bn |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn | 2.09 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 1.59 Bn |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn | 392.40 Mn |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn | 18.00 Mn |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn | 478.40 Mn |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Nexalin Technology | 3.42 Mn | 2.41 Mn | 8,897.00 | 3,264.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,264.00 |
| Mar 31, 2026 | 1,817.00 |
| Dec 31, 2025 | 21,029.00 |
| Sep 30, 2025 | 3,948.00 |
| Jun 30, 2025 | 22,838.00 |
| Mar 31, 2025 | 13,558.00 |
| Dec 31, 2024 | 7,496.00 |
| Sep 30, 2024 | 12,694.00 |
| Jun 30, 2024 | 7,247.00 |
| Mar 31, 2024 | 9,156.00 |
| Dec 31, 2023 | 5,231.00 |
| Sep 30, 2023 | 3,973.00 |
| Jun 30, 2023 | 9,374.00 |
| Mar 31, 2023 | 7,110.00 |
| Dec 31, 2022 | 6,867.00 |
| Sep 30, 2022 | 187,298.00 |
| Jun 30, 2022 | 123,032.00 |
| Mar 31, 2022 | 46,015.00 |
| Dec 31, 2021 | -1,006.00 |
| Sep 30, 2021 | 9,306.00 |